Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L3KR
|
||||
Former ID |
DNC013339
|
||||
Drug Name |
2,2',4,4'-tetrahydroxy-6'-methoxychalcone
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C16H14O6
|
||||
Canonical SMILES |
COC1=CC(=CC(=C1C(=O)C=CC2=C(C=C(C=C2)O)O)O)O
|
||||
InChI |
1S/C16H14O6/c1-22-15-8-11(18)7-14(21)16(15)12(19)5-3-9-2-4-10(17)6-13(9)20/h2-8,17-18,20-21H,1H3/b5-3+
|
||||
InChIKey |
NNOIQNQJIKZQCN-HWKANZROSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Tyrosine oxidase | Target Info | Inhibitor | [1] | |
BioCyc Pathway | (S)-reticuline biosynthesis | ||||
Eumelanin biosynthesis | |||||
L-dopachrome biosynthesis | |||||
KEGG Pathway | Tyrosine metabolism | ||||
Riboflavin metabolism | |||||
Metabolic pathways | |||||
Melanogenesis | |||||
PathWhiz Pathway | Riboflavin Metabolism | ||||
Tyrosine Metabolism | |||||
WikiPathways | Dopamine metabolism | ||||
References | |||||
REF 1 | Bioorg Med Chem. 2007 Mar 15;15(6):2396-402. Epub 2007 Jan 17.Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.